Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Robinhood Investors Are Buying Tonix Pharmaceuticals Stock
MTFL
now I understand why it doesn't go up!
I am here ready to enter!
I hope they give me a good entry point!
I think this is a right day
Liquidity and Financial Condition As of December 31, 2020, the Company had cash and cash equivalents, excluding restricted cash, of $89.8 million, total current assets of $91.8 million and total current liabilities of $13.5 million.
MC $162 mil
when air traffic resumes it can only fly
I think the toxic securities are those of the banks and not BLUE!
Now you understand why they pumped for the banking sector!
unbelievable!
I don't sell BLUE, I keep them tight!
fair value 40/45$!
1,3b cash
Why does is not so positive for BMY?
Because the approval took place in the US which is blue's market
and
As part of the Celgene-Bristol Myers deal, Celgene shareholders would have received a $ 9 per share payment if three of Celgene's top pipeline assets were approved by certain dates.
distressed shorts!
Did Archegos Capital buy Blue?
You'd like it!
Who sells now is either a shit or a jerk!
DECEMBER 31, 2020, CASH AND CASH EQUIVALENTS TOTALED $77.1
GEN 17, 2021 Tonix Pharmaceuticals Holdings Closes $40 Mln Common Stock Offering Priced At-The-Market
FEB 9, 2021 Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering Priced At-The-Market
So go and vote no or don't go for the quorum, that's the dilemma!
They have time to raise the base unless someone puts undue pressure!
In every case shorts they are making it out of the cup!
if you want to see a super short squeeeze vote no to the meeting!
Vote NO
then let's see how they cover!
A Special Meeting of the shareholders of Tonix Pharmaceuticals Holding Corp. (the “Company” or “Tonix”) will be held on Friday, March 26, 2021, at 11:00 a.m.
Eastern Daylight Time
I have decided
I buy more!
I feel bad luck is pouring on the shorts!
Beware that money karma doesn't care
Shorty, why did you short it so heavily?
I do not sell!
I like it!
today then... https://mvest-prod.s3.amazonaws.com/assets/egvc2021/documents/Day+3.pdf
https://insider-analysis.com/search_transactions.php?ticker=TABLE_TNXP
There is a dire need for safe and long-lasting vaccines!
I do not sell!
reading here and there
Humanitarian Device Exemption (HDE)
Alternatively, a Class III device may qualify for FDA approval to be distributed under an HDE rather than a PMA. For a device to be eligible for an HDE, it must be first designated by the FDA as a HUD intended to benefit patients in the treatment or diagnosis of a disease or condition that affects fewer than 8,000 individuals in the United States per year (increased by the 21st Century Cures Act from 4,000 to 8,000). The HDE pathway also requires that there must be no other comparable device available to provide therapy for this condition. An HDE application is similar in form and content to a PMA and, although exempt from the effectiveness requirements of a PMA, an HDE does require sufficient information for the FDA to determine that the device does not pose an unreasonable or significant risk of illness or injury, and that the probable benefit to health outweighs the risk of injury or illness from its use. In addition, a HUD may only be used in facilities that have established a local institutional review board, or IRB, to supervise clinical testing of devices, and after an IRB has approved the use of the device to treat or diagnose the specific disease.
In addition, except in certain circumstances, products approved under an HDE cannot be sold for an amount that exceeds the costs of research and development, fabrication, and distribution of the device (i.e., for profit). Currently, a product is only eligible to be sold for profit after receiving HDE approval if the device (1) is intended for the treatment or diagnosis of a disease or condition that occurs in pediatric patients or in a pediatric subpopulation, and such device is labeled for use in pediatric patients or in a pediatric subpopulation in which the disease or condition occurs; or (2) is intended for the treatment or diagnosis of a disease or condition that does not occur in pediatric patients or that occurs in pediatric patients in such numbers that the development of the device for such patients is impossible, highly impracticable, or unsafe. If an HDE-approved device does not meet either of the eligibility criteria, the device cannot be sold for profit. We expect our Neuro-Spinal Scaffold implant may meet the eligibility criteria to be sold for a profit.
No he didn't take it from me!
i loaded at 2.04
Bloom Burton Bean
https://www.bloomburton.com/titan-medical-announces-closing-of-us-23m-bought-deal-offering-including-full-exercise-of-over-allotment-option/
and exercised its over-allotment option in full on the date hereof for an additional 1,250,250 Units and additional gross proceeds to the Company of US $3,000,600.
A little bit of Sboom!
Talk to the daughter-in-law so that the mother-in-law understands ...
In the hope that they understand ...
Ready to add!
In the hope that some proud(-one) will take the longest step of the leg!
I hope Susan sees the light, what she experiences is a very tough test!
The harder the test, the more glorious the triumph!
OTB
cover cover cover cover cover ...
Mmmm Monday
I have a feeling that milestone three is very close!
look at the dates in these other two
https://uspto.report/patent/grant/10,772,703
https://uspto.report/patent/grant/10820953
marks 10 days over $ 1!
fizzlin moment
2021-02-16 13G/A Altium Capital Management LP 206,875 9.99
2021-02-11 13G Hudson Bay Capital Management LP 1,335,447 9.99
2021-01-28 13G/A Empery Asset Management, LP 1,047,364 9.99
2020-09-24 13D/A TardiMed Sciences LLC 5,437,517 45.20
TP 37
The data is reasonably good!
when they add the stem cells then they will understand if it is something promising!
more than weak hands here waiting for those who eiculate soon!
how can you settle for 2 barrel?
Ah how you tempt me!
I m in
The CEO is constipated!
He has already talked too much!
In Brief
Researchers investigated the safety and neurological recovery results in patients with complete (i.e., no function below the level of injury) thoracic spinal cord injury who were implanted with a novel bioresorbable scaffold (Neuro-Spinal Scaffold) during open spine surgery. The results from this first-in-human study are important because they demonstrate that the potential benefits of the Neuro-Spinal Scaffold outweigh the risks in this patient population and support further clinical investigation in a randomized controlled trial.
they look very positive!
Get out weak hands, it will take off!
Maybe tomorrow or later
RESULTS
Nineteen patients underwent NSS implantation. There were 3 early withdrawals due to death, which were all determined by investigators to be unrelated to the NSS or the implantation procedure. Seven of 16 patients (43.8%) who completed the 6-month follow-up visit had conversion of neurological status (AIS grade A to grade B [n = 5] or C [n = 2]). Five patients showed improvement in NLI of 1 to 2 levels compared with preimplantation assessment, 3 patients showed no change, and 8 patients showed deterioration of 1 to 4 levels. There were no unanticipated or serious adverse device effects or serious adverse events related to the NSS or the implantation procedure as determined by investigators.
CONCLUSIONS
In this first-in-human study, implantation of the NSS within the spinal cord appeared to be safe in the setting of surgical decompression and stabilization for complete (AIS grade A) thoracic SCI. It was associated with a 6-month AIS grade conversion rate that exceeded historical controls. The INSPIRE study data demonstrate that the potential benefits of the NSS outweigh the risks in this patient population and support further clinical investigation in a randomized controlled trial.
RSI 7 Buy
RSI 25 Hold
Since I will add in the next few days, don't let it go too high!
Thank you
So please close at $7
I need to add other TMDI!
https://www.srobotics.org/virtual-meeting/
Why was TMDI present? Who gave them 9 minutes?
Why?
Because of this
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=%22titan+medical%22&OS=%22titan+medical%22&RS=%22titan+medical%22
and others...
Goldmine
Golden Cross
66/67
Enos
Huge Market
Timely manner
OTB
Renaissance Technologies Llc reentry
Quantum hedge founds
Is cup and handle pattern forming?
I would look at the graph per year
Ahah
TMBR in the race!
I noticed it because someone called him and I noticed that every time he goes up here they call him!
will it be a coincidence?
I have to thank for the tip! wanted or not!
Yup
but I prefer TMDI!
For us TRXC is a good index, if they manage to stay on the market it will be easier for us!
Enos have snakes